Scott Innis, Associate Director of Market Assessment, Biogen Idec

Scott Innis is currently an Associate Director of Market Assessment in the New Product Commercialization team at Biogen Idec. Prior to joining Biogen in October 2011, he was an Engagement Manager at Leerink Swann Consulting, the strategy consulting group at healthcare investment bank, Leerink Swann, LLC.. During his tenure at Leerink, Scott served as a consultant to an array of pharmaceutical, biotech, and other life sciences organizations with a focus on new product planning, product and franchise growth strategies and product and corporate due diligence. Previous to Leerink, Scott was a Product Manager at Altus Pharmaceuticals Inc., with responsibility for the company's lead product candidate, in cystic fibrosis and chronic pancreatitis and also held various strategically-oriented positions focused on business and commercial development, product marketing, and new product planning. Scott received his MS in Biotechnology from the J.L. Kellogg Center for Biotechnology at Northwestern University and his BS in Zoology from Miami University in Oxford, OH.